On Wednesday (May 23) a venture cannabis company announced a partnership with an up and coming retail operator to enhance retail distribution and create branded cannabis lounges.

The partnership is between Newstrike Resources (TSXV:HIP), who made an official a strategic investment partnership with Inner Spirit Holdings. According to the announcement, both companies will obtain equity interests in the other and begin working on the retail distribution of Up Cannabis, Newstrike’s main recreational brand, products. The partnership will also work to develop “experiential hubs” for future consumers.

“We look forward to working with Spiritleaf to enhance Up’s distribution reach and successfully building our businesses in a complementary and strategically aligned manner,” Jay Wilgar, CEO of Newstrike said in a statement.

This partnership will cost Newstrike approximately and aggregate value of C$1.12 million worth of shares at C$0.90 per share plus C$1.125 million in cash. Newstrike’s previous closing price for Wednesday was C$0.87 per share.

As part of the deal Inner Spirit will issue 15 million units of the company, at a price of C$0.15 per unit, to Newstrike during the company’s proposed initial public offering.

The announcement confirmed Inner Spirit’s stock will be listed on the Canadian Securities Exchange (CSE). The company plans to launch its stock through an initial public offering (IPO) offering of  7 million units minimum and 15 million at most for a C$0.15 price per unit. Inner Spirit expects gains between a range of roughly C$1 million and C$2.25 million

Last November, Inner Spirit announced the execution of 55 franchise agreements across Canada with the intention to convert these into legal recreational cannabis dispensaries.

The retail cannabis space company boasts of owning a membership to the Canadian Franchise Association and working on the development of over 100 franchises.

Darren Bondar, president and CEO of Inner Spirit said this partnership will allow for future consumers to obtain an all around combination experience of “cannabis, music, education and community.”

Following Wednesday’s announcement, shares of Newstrike dipped 18.39 percent to $0.71 as of 2:49 p.m. EST on Thursday (May 24).

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company will have senior management participating in the following virtual financial community conferences and events during December 2020 .

  • Roth Deer Valley Consumer Conference – December 9 th to 11 th , 2020
  • Cantor Fitzgerald 2020 Virtual Cannabis MSO Summit – December 15 th to 16 th , 2020
  • MKM Partners – The Road Ahead, Preparation for 2021 Conference – December 15 th to 16 th , 2020

For more information regarding upcoming Curaleaf financial community conference and event participation please visit the investor relations section of the company website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less